Tranzactioneaza VERU INC (US.VERU) - 3.06 USD (%) Tranzactioneaza
Indici
Descriere companie
Veru Inc. (https://verupharma.com/) is an oncology biopharmaceutical company. The Company is focused on developing novel medicines for the management of prostate and breast cancers. It operates through two segments: Sexual Health Business and Research and Development. The Sexual Health Business segment includes a drug candidate, TADFYN, for the treatment of benign prostatic hyperplasia (BPH) and a commercial product, the FC2 Female Condom/ Internal Condom (FC2). The Research and Development segment includes multiple products and management evaluating each product in its portfolio of products. The Company's prostate cancer drug pipeline includes Sabizabulin (VERU-111), VERU-100 and Zuclomiphene citrate. Sabizabulin (VERU-111) is an oral chemical entity that targets and inhibits microtubules to disrupt transport of the androgen receptor into the nucleus (androgen receptor transport disruptor). VERU-100 for androgen deprivation therapy (ADT) of advanced prostate cancer.